World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
26176
World Ranking
13245
National Ranking
6746

Overview

Sofia D. Merajver is affiliated with the University of Michigan-Ann Arbor in the United States. Their research spans multiple fields within medicine and biochemistry, genetics, and molecular biology, with a strong focus on oncology and cancer-related studies.

Their primary fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, they have contributed extensively to subfields such as:

  • Molecular Biology
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research
  • Genetics

The main topics covered in their work are:

  • BRCA gene mutations in cancer
  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Cancer, Hypoxia, and Metabolism
  • Brain Metastases and Treatment
  • Lung Cancer Research Studies
  • Cancer Cells and Metastasis

They have published frequently in the following venues:

  • Cancer Research
  • Journal of Clinical Oncology
  • Journal of the National Comprehensive Cancer Network
  • The Journal of Urology
  • Clinical Cancer Research

Among notable recent papers coauthored or authored by Sofia D. Merajver are:

  • Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology (2021), Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020 (2020), Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024 (2023), Journal of the National Comprehensive Cancer Network
  • TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination (2020), Journal of Clinical Investigation
  • G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy (2021), Science Advances

Their frequent co-authors include:

  • Nathan Merrill
  • Matthew B. Soellner
  • Liwei Bao
  • Peter Ulintz
  • Habib Serhan

Best Publications

  • The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.

    S.V. Tavtigian;J. Simard;J. Rommens;F. Couch

  • Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 2.2021

    Mary B. Daly;Tuya Pal;Michael P. Berry;Saundra S. Buys

  • BRCA1 regulates human mammary stem/progenitor cell fate

    Suling Liu;Christophe Ginestier;Emmanuelle Charafe-Jauffret;Hailey Foco

  • NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

    Mary B. Daly;Robert Pilarski;Michael Berry;Saundra S. Buys

  • International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

    S. Dawood;S. D. Merajver;P. Viens;P. B. Vermeulen

  • Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

    Sofia D. Merajver;Trinh M. Pham;Rosemarie F. Caduff;Martha Chen

  • Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.

    Quintin Pan;Celina G. Kleer;Kenneth L. Van Golen;Jennifer Irani

  • Assessment and Counseling for Women With a Family History of Breast Cancer: A Guide for Clinicians

    Kent F. Hoskins;Jill E. Stopfer;Kathleen A. Calzone;Sofia D. Merajver

  • Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

    Steven A. Narod;Marie Pierre Dubé;Jan Klijn;Jan Lubinski

  • NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.

    Mary B. Daly;Robert Pilarski;Matthew B. Yurgelun;Michael P. Berry

  • RhoC GTPase, a Novel Transforming Oncogene for Human Mammary Epithelial Cells That Partially Recapitulates the Inflammatory Breast Cancer Phenotype

    Kenneth L. van Golen;Zhi-Fen Wu;Xiao Tan Qiao;Li Wei Bao

  • BRCA2 germline mutations in male breast cancer cases and breast cancer families.

    Fergus J. Couch;Linda M. Farid;Michelle L. DeShano;Sean V. Tavtigian

  • Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study

    George J. Brewer;Robert D. Dick;Damanjit K. Grover;Virginia LeClaire

  • International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

    Kelly A. Metcalfe;Daphna Birenbaum-Carmeli;Jan Lubinski;Jacek Gronwald

  • Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy in BRCA1/2-Associated Stage I/II Breast Cancer

    Lori J. Pierce;Albert M. Levin;Timothy R. Rebbeck;Merav A. Ben-David

  • A Novel Putative Low-Affinity Insulin-like Growth Factor-binding Protein, LIBC (Lost in Inflammatory Breast Cancer), and RhoC GTPase Correlate with the Inflammatory Breast Cancer Phenotype

    Kenneth L. Van Golen;Seena Davies;Zhi Fen Wu;Yun Fang Wang

  • Genetic/familial high-risk assessment: Breast and ovarian, version 2.2015 Featured updates to the NCCN guidelines

    Mary B. Daly;Robert Pilarski;Jennifer E. Axilbund;Michael Berry

  • Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23

    B. Fisher;S. Anderson;E. Tan-Chiu;N. Wolmark

  • BRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants

    Fons Elstrodt;Antoinette Hollestelle;Jord H.A. Nagel;Michael Gorin

  • Characterization of RhoC expression in benign and malignant breast disease: A potential new marker for small breast carcinomas with metastatic ability

    Celina G. Kleer;Kenneth L. Van Golen;Yanhong Zhang;Zhi Fen Wu

Frequent Co-Authors

Celina G. Kleer
Celina G. Kleer University of Michigan–Ann Arbor
George J. Brewer
George J. Brewer University of Michigan–Ann Arbor
Max S. Wicha
Max S. Wicha University of Michigan–Ann Arbor
Judy Garber
Judy Garber Harvard University
Lisa A. Newman
Lisa A. Newman Cornell University
Mary B. Daly
Mary B. Daly Fox Chase Cancer Center
Theodoros N. Teknos
Theodoros N. Teknos The Ohio State University
Kenneth Offit
Kenneth Offit Memorial Sloan Kettering Cancer Center
Jeffrey N. Weitzel
Jeffrey N. Weitzel Natera (United States)
Jun Li
Jun Li University of Oklahoma Health Sciences Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medical careers beyond the traditional path of an MD in the USA, several flexible online options are available. Healthcare administration is a growing field for those who want leadership roles in medical settings. Choosing from which online healthcare administration programs have cahme accreditation? ensures your degree is recognized for its quality and rigor, providing a competitive edge in the job market.

Nursing is another high-demand sector. RNs looking to advance without extensive in-person requirements should explore rn to bsn programs no clinicals. These programs are ideal for working nurses seeking to upgrade their qualifications at their own pace.

For nurses ready to take on top clinical and leadership roles, Doctor of Nursing Practice degrees are becoming more accessible online. Options like the quickest dnp program or searching for dnp programs tailored for working professionals can accelerate your path to advanced practice. Each of these pathways allows you to expand your impact in healthcare while balancing your work and personal commitments.

Best Scientists Citing Sofia D. Merajver

Trending Scientists

Recently Published Articles